Aposense (Formerly NeuroSurvival Technologies) is a biopharmaceutical company that focuses on developing innovative products, diagnostics, and therapies for the detection, delay and intervention in Apoptosis processes (programmed cell death). Apoptosis is a gene-based self-destructive program that exists in every cell of the human body. The discovery of this "suicidal" cellular activity constitutes a major scientific advancement. Interference in the Apoptosis suicidal process represents a major breakthrough in the inhibition of numerous Central Nervous System degenerative disorders, such as Parkinson's, Alzheimer's, and various cancers.